Archive

Posts Tagged ‘KGaA’

European Stocks Decline as Philips, Merck KGaA Fall; Man Climbs

June 22nd, 2011 Comments off

European stocks fell, retreating after the Stoxx Europe 600 Index’s biggest gain in two months, as Royal Philips Electronics NV tumbled.
BusinessWeek.com — Finance

Oncothyreon (NASDAQ: ONTY) $106M (MarketCap) Back in the Game as Merck KGaA Re-Starts Clinical Trials

December 17th, 2010 Comments off

Oncothyreon (NASDAQ: ONTY) 6M (MarketCap) Back in the Game as Merck KGaA Re-Starts Clinical Trials

{image}

Oncothyreon (NASDAQ: ONTY) 6M (MarketCap) Back in the Game as Merck KGaA Re-Starts Clinical Trials

Free Online Articles Directory

AB Answers

0 && $ .browser.msie ) {
var ie_version = parseInt($ .browser.version);

via

Hello


Password



Lost ?

Home Page > Finance > Day Trading > Oncothyreon (NASDAQ: ONTY) 6M (MarketCap) Back in the Game as Merck KGaA Re-Starts Clinical Trials

Oncothyreon (NASDAQ: ONTY) 6M (MarketCap) Back in the Game as Merck KGaA Re-Starts Clinical Trials

Edit Article |

Posted: Jun 17, 2010 |Comments: 0

|

Share

Oncothyreon (NASDAQ: ONTY) is a Seattle-based biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. The company’s overall goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. Earlier this year, it partnered with German-based Merck KGaA (MRCG.DE) to run clinical trials on an immune-boosting therapy. These consisted of two lung cancer trials known as Start and Inspire as well as a breast cancer study called Stride. The three trials, all of which involve the BLP25 liposomal vaccine (Stimuvax), consisted of a combined 2,600 patients. On March 23rd, one of the patients developed an unexpected inflammation of the brain, known as encephalitis, forcing all of Merck’s 3 pivotal trials on humans to go on hold until researchers could figure out whether it was really safe to continue. Following this news, Oncothyreon shares plummeted 27% that day and have not recovered since.

Today, Oncothyreon can breathe a sigh of relief. The company has announced that its German partner has received FDA clearance to re-start 2 of 3 clinical trials of their experimental cancer vaccine Stimuvax on lung-cancer patients, reviving hopes for a key pipeline drug. The Phase III Stride trial in breast cancer remains suspended. In response to this news, the biotech firm’s shares were up 6.9% in Frankfurt before Wall Street opened today. Currently, the company is trading at .11, up .50 or 13.85%.

Oncothyreon has no marketed products, but it has other cancer drugs in its pipeline besides the BLP25-based immune booster. Its partner, Merck, is primarily responsible for the development of this program, while Oncothyreon, accounting for a large portion of the value investors assign to the company, stands to collect royalties on product sales if the treatment is successful.

 

“The resumption of the BLP25 liposome vaccine clinical program is very good news for the oncology community and non-small cell lung cancer patients. If the Start and Inspire Phase III trials are successful, BLP25 liposome vaccine could play an important role in the treatment of these currently underserved patients,” said Dr. Frances Shepherd, director of the Medical Oncology Princess Margaret Hospital in Toronto, Canada, and an investigator of the Start trial, in an Oncothyreon statement.

 

To view this article at World Market Media click on the link below: http://www.worldmarketmedia.com/779/section.aspx/1870/post/oncothyreon-nasdaq-onty-106m-marketcap-back-in-the-game-as-merck-kgaa-re-starts-clinical-trials
 

Disclosure: no positions

Retrieved from “http://www.articlesbase.com/day-trading-articles/oncothyreon-nasdaq-onty-106m-marketcap-back-in-the-game-as-merck-kgaa-re-starts-clinical-trials-2663965.html”

(ArticlesBase SC #2663965)

Liked this article? Click here to publish it on your website or blog, it’s free and easy!

World Market Media -
About the Author:

About World Market Media:
WorldMarketMedia.com (The Global Online Investment Community) is a high traffic stock market, news data website providing cutting edge new media products and services to publicly traded companies worldwide. Our Editor’s Desk authors insightful real-time coverage on the economy, the capital markets and their listed companies.

Questions and Answers

Ask our experts your Day Trading related questions here…200 Characters left

How many patients in clinical trials ?
What is the value of the first night game at wrigley field starting line up card?
Why are these games called the commonwealth games? who started these games?

Rate this Article

1
2
3
4
5

0

Feedback

Print

Re-Publish

Source:  http://www.articlesbase.com/day-trading-articles/oncothyreon-nasdaq-onty-106m-marketcap-back-in-the-game-as-merck-kgaa-re-starts-clinical-trials-2663965.html

Article Tags:
biotechnology, germany, medical vaccines, nasdaq, onty, wolrd market media stocks onty

Latest Day Trading Articles
More from World Market Media

Basics Of Stock Trading

There are so many people around the globe who have the same dream to get rich as soon as possible and the stock market is one such place which makes the peoples dream come true in the very less period of time as compared to the other conventional trades and business in which the success is there but not so fast.

By:
Jullyl

Finance>
Day Tradingl
Dec 16, 2010

Few Tips By Which You Can Make Profit In Stock Market

When a person believes that he or she has enough extra money and you want to invest this extra money some where from where you can earn big profits and have a nice earning and living for the future then doing online stock trading is very good option.

By:
Jullyl

Finance>
Day Tradingl
Dec 16, 2010

Best Forex Trader Review Tips

Currency trade in the Forex Trading Market is huge and can be a great opportunity for those interested in getting involved with Forex. For those searching other alternatives to making money, Forex Trading could well be a welcomed career move, especially in the current economic climate.

By:
David Rayl

Finance>
Day Tradingl
Dec 15, 2010

The Fed Is Walking The Bond Yield Tightrope

Since the Federal Reserve Bank announced it’s 0 billion quantitative easing program on November 3rd, 2010 yields on the 10 and 30 Year Treasury Notes have soared higher. On November 4th the 10 Year Treasury yield was around 2.46 percent and the 30 Year Treasury yield was around 3.85 percent. Since that time the 10 Year T- Bond yield jumped by more than a full point and is now trading around 3.55 percent. The yield on the 30 Year T-Note is now around 4.60 percent.

By:
Nicholas Santiagol

Finance>
Day Tradingl
Dec 15, 2010

The Federal Reserve Versus Common Sense

A bubble has started to inflate and once again the Federal Reserve has a direct relationship with it. The markets have soared over the last few months as the SPDR S&P 500 ETF (NYSE:SPY) has gone from 4.50 to a recent high of 5.20. This move has lifted the SPY twenty percent. Behind the move is the Federal Reserve, printing and pumping money into the system to create an asset bubble. As they print, the Dollar declines and in response, all assets must adjust their prices higher.

By:
Gareth Solowayl

Finance>
Day Tradingl
Dec 15, 2010

Does Seasonal Financial Trading Actually Work?

Many of us are curious as to how and why the markets move as they do. Some so called experts will claim you can never beat the markets as they are purely random. However is this really true?

By:
Neil Mannl

Finance>
Day Tradingl
Dec 15, 2010

Learn How the Financial Markets Really Move

Have you ever wondered why so many so called experts call the market incorrectly? Many experts rely on other experts to indicate a general trend and what then follows is a herd mentality which is then reflected in articles and press reports that you read in your newspapers and elsewhere. Of course there are exceptions to this and some experts really do seem to have an incredible knack for calling the market whether it be for the market to move higher or lower.

By:
Neil Mannl

Finance>
Day Tradingl
Dec 15, 2010

Stock Trading Education and Analysis

If you want to make handsome money in stock trading you must look for professional stock market advice. On internet you can easily find out various companies offering stock trading education for traders of all capacity.

By:
william kadutzil

Finance>
Day Tradingl
Dec 15, 2010

Expected Pullback after Monday Gap Open

When markets gap around they get natural retracements creating volatility and if you look at a simple 5 day chart you can spot likely retracements. An example is yesterdays gap higher and todays pullback which will likely test the area it gapped from. News becomes irrelevant and pricing takes over as valuation becomes a confusing exercise making it best to trudge through the summer and its earnings quarter.

By:
World Market Medial

Marketing>
International Marketingl
Aug 04, 2010

AI Systems, Inc. Takes Flight with New Technology (OTCBB: ASYI)

Our technology revolutionizes how the airline industry will create business plans and schedules, the very core of their business. We have taken tremendously complex technology and created an elegant and simple user interface that can be used by an airline CEO, CFO, COO or any senior planner.”

By:
World Market Medial

Finance>
Currency Tradingl
Aug 04, 2010

Cereplast (Nasdaq:CERP): Rail Access for New Facility

Cereplast, Inc. (NASDAQ: CERP) a leading manufacturer of proprietary bio-based, sustainable plastics, announced today that it will soon have access to rail freight service at its recently opened facility in Seymour, Indiana.The rail spur, which is located at Seymour’s Eastside Industrial Park, will enable Cereplast to bulk ship its proprietary biodegradable plastic resins to its growing client base across the United States, and directly to U.S. port cities for shipment to clients in Asia, Europe

By:
World Market Medial

Finance>
Currency Tradingl
Aug 04, 2010

Media Earnings Ahead: Ad Dollars Still in Dysfunction Mode

One of the most difficult sectors of the stock market to pick in 2010 are Media Companies, most Portfolio Managers missed the move in the past fiscal year because Google (NASDAQ: GOOG) is an active disruptive technology which has upset the apple cart.

By:
World Market Medial

Finance>
Day Tradingl
Jul 31, 2010

CopSync (OTCBB: COYN): 8 More Sign Up’s

(OTCBB: COYN ), a software technology provider to law enforcement and emergency service professionals, announces today that eight additional Texas law enforcement agencies have implemented the Company’s COPsync(TM) real-time mobile data information sharing software.

By:
World Market Medial

Finance>
Investingl
Jul 31, 2010

HSW Intl. (Nasdaq: HSWI) : How Stuff Works +40% Online Content China

This is the second time I’ve written an artcile where this company was up big.

By:
World Market Medial

Finance>
Day Tradingl
Jul 31, 2010

Rocky Brands (Nasdaq: RCKY) Up after Posting Second Quarter Profit

After posting second quarter results yesterday, Rocky Brands (Nasdaq: RCKY) shares were up 9% to .00 on heavy volume.

By:
World Market Medial

Finance>
Investingl
Jul 31, 2010

Rocky Brands (Nasdaq: RCKY) Up after Posting Second Quarter Profit

After posting second quarter results yesterday, Rocky Brands (Nasdaq: RCKY) shares were up 9% to .00 on heavy volume.

By:
World Market Medial

Finance>
Day Tradingl
Jul 31, 2010

Add new Comment

Your :

 

Your Articles Here
It’s Free and easy

Sign Up Today

Author Navigation

My Home

View/Edit Q&A

Personal

My Home

View/Edit Q&A

Author Box

World Market Media has 304 articles online

Contact Author

Subscribe to

Print article

Send to friend

Re-Publish article

Articles Categories
All Categories

Arts & Entertainment
Automotive
Beauty
Business
Careers
Computers
Education
Finance
Food and Beverage
Health
Hobbies
Home and Family
Home Improvement
Internet
Law
Marketing
News and Society
Relationships
Self Improvement
Shopping
Spirituality
Sports and Fitness
Technology
Travel
Writing

Finance

Accounting
Banking
Credit
Currency Trading
Day Trading
Debt Consolidation
Insurance
Investing
Loans
Mortgage
Personal Finance
Real Estate
Taxes
Wealth Building

Need Help?

Site Links

Webmasters

Business Info

Use of this web site constitutes acceptance of the Terms Of Use and Privacy Policy | User published content is licensed under a Creative Commons License.
Copyright © 2005-2010 Free Articles by ArticlesBase.com, All rights reserved.

Categories: Uncategorized Tags: , , , , , , , , , , ,

Oncothyreon (NASDAQ: ONTY) $106M (MarketCap) Back in the Game as Merck KGaA Re-Starts Clinical Trials

December 16th, 2010 Comments off

Oncothyreon (NASDAQ: ONTY) 6M (MarketCap) Back in the Game as Merck KGaA Re-Starts Clinical Trials

{image}

Oncothyreon (NASDAQ: ONTY) 6M (MarketCap) Back in the Game as Merck KGaA Re-Starts Clinical Trials

Free Online Articles Directory

AB Answers

0 && $ .browser.msie ) {
var ie_version = parseInt($ .browser.version);

via

Hello


Password



Lost ?

Home Page > Finance > Day Trading > Oncothyreon (NASDAQ: ONTY) 6M (MarketCap) Back in the Game as Merck KGaA Re-Starts Clinical Trials

Oncothyreon (NASDAQ: ONTY) 6M (MarketCap) Back in the Game as Merck KGaA Re-Starts Clinical Trials

Edit Article |

Posted: Jun 18, 2010 |Comments: 0

|

Share

Oncothyreon (NASDAQ: ONTY) is a Seattle-based biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. The company’s overall goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. Earlier this year, it partnered with German-based Merck KGaA (MRCG.DE) to run clinical trials on an immune-boosting therapy. These consisted of two lung cancer trials known as Start and Inspire as well as a breast cancer study called Stride. The three trials, all of which involve the BLP25 liposomal vaccine (Stimuvax), consisted of a combined 2,600 patients. On March 23rd, one of the patients developed an unexpected inflammation of the brain, known as encephalitis, forcing all of Merck’s 3 pivotal trials on humans to go on hold until researchers could figure out whether it was really safe to continue. Following this news, Oncothyreon shares plummeted 27% that day and have not recovered since.

Today, Oncothyreon can breathe a sigh of relief. The company has announced that its German partner has received FDA clearance to re-start 2 of 3 clinical trials of their experimental cancer vaccine Stimuvax on lung-cancer patients, reviving hopes for a key pipeline drug. The Phase III Stride trial in breast cancer remains suspended. In response to this news, the biotech firm’s shares were up 6.9% in Frankfurt before Wall Street opened today. Currently, the company is trading at .11, up .50 or 13.85%.

Oncothyreon has no marketed products, but it has other cancer drugs in its pipeline besides the BLP25-based immune booster. Its partner, Merck, is primarily responsible for the development of this program, while Oncothyreon, accounting for a large portion of the value investors assign to the company, stands to collect royalties on product sales if the treatment is successful.

 

“The resumption of the BLP25 liposome vaccine clinical program is very good news for the oncology community and non-small cell lung cancer patients. If the Start and Inspire Phase III trials are successful, BLP25 liposome vaccine could play an important role in the treatment of these currently underserved patients,” said Dr. Frances Shepherd, director of the Medical Oncology Princess Margaret Hospital in Toronto, Canada, and an investigator of the Start trial, in an Oncothyreon statement.

 

To view this article at World Market Media click on the link below: http://www.worldmarketmedia.com/779/section.aspx/1870/post/oncothyreon-nasdaq-onty-106m-marketcap-back-in-the-game-as-merck-kgaa-re-starts-clinical-trials
 

Disclosure: no positions

Retrieved from “http://www.articlesbase.com/day-trading-articles/oncothyreon-nasdaq-onty-106m-marketcap-back-in-the-game-as-merck-kgaa-re-starts-clinical-trials-2672161.html”

(ArticlesBase SC #2672161)

Liked this article? Click here to publish it on your website or blog, it’s free and easy!

World Market Media -
About the Author:

 

About World Market Media:
WorldMarketMedia.com (The Global Online Investment Community) is a high traffic stock market, news data website providing cutting edge new media products and services to publicly traded companies worldwide. Our Editor’s Desk authors insightful real-time coverage on the economy, the capital markets and their listed companies.

Questions and Answers

Ask our experts your Day Trading related questions here…200 Characters left

How many patients in clinical trials ?
What is the value of the first night game at wrigley field starting line up card?
Why are these games called the commonwealth games? who started these games?

Rate this Article

1
2
3
4
5

0

Feedback

Print

Re-Publish

Source:  http://www.articlesbase.com/day-trading-articles/oncothyreon-nasdaq-onty-106m-marketcap-back-in-the-game-as-merck-kgaa-re-starts-clinical-trials-2672161.html

Article Tags:
onty, biotechnology, germany, medical vaccines, nasdaq, wolrd market media

Related Videos

Related Articles

Latest Day Trading Articles
More from World Market Media

Learn about the NASDAQ Index

Learn about the nasdaq index in this series of financial advice videos. (00:46)

How to Invest in the Stock Market

Weekly Wrap Up of the Markets S&P 500 DOW Jones NASDAQ Crude Oil
Market Wrap: S&P500, NASDAQ, DOW, CRUDE OIL, Gold (06:06)

Asian Markets Rebound

Federal Reserve will pump money into Greece, in a dollar-swap program that matches the Central Bank’s equivalent in foreign currency. Plus: NYSE and NASDAQ chiefs to meet with federal regulators regarding Thursday’s market plummet. (02:03)

Oncothyreon (NASDAQ: ONTY) 6M (MarketCap) Back in the Game as Merck KGaA Re-Starts Clinical Trials

Oncothyreon (NASDAQ: ONTY) is a Seattle-based biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer.

By:
World Market Medial

Finance>
Day Tradingl
Jun 17, 2010

Basics Of Stock Trading

There are so many people around the globe who have the same dream to get rich as soon as possible and the stock market is one such place which makes the peoples dream come true in the very less period of time as compared to the other conventional trades and business in which the success is there but not so fast.

By:
Jullyl

Finance>
Day Tradingl
Dec 16, 2010

Few Tips By Which You Can Make Profit In Stock Market

When a person believes that he or she has enough extra money and you want to invest this extra money some where from where you can earn big profits and have a nice earning and living for the future then doing online stock trading is very good option.

By:
Jullyl

Finance>
Day Tradingl
Dec 16, 2010

The Fed Is Walking The Bond Yield Tightrope

Since the Federal Reserve Bank announced it’s 0 billion quantitative easing program on November 3rd, 2010 yields on the 10 and 30 Year Treasury Notes have soared higher. On November 4th the 10 Year Treasury yield was around 2.46 percent and the 30 Year Treasury yield was around 3.85 percent. Since that time the 10 Year T- Bond yield jumped by more than a full point and is now trading around 3.55 percent. The yield on the 30 Year T-Note is now around 4.60 percent.

By:
Nicholas Santiagol

Finance>
Day Tradingl
Dec 15, 2010

The Federal Reserve Versus Common Sense

A bubble has started to inflate and once again the Federal Reserve has a direct relationship with it. The markets have soared over the last few months as the SPDR S&P 500 ETF (NYSE:SPY) has gone from 4.50 to a recent high of 5.20. This move has lifted the SPY twenty percent. Behind the move is the Federal Reserve, printing and pumping money into the system to create an asset bubble. As they print, the Dollar declines and in response, all assets must adjust their prices higher.

By:
Gareth Solowayl

Finance>
Day Tradingl
Dec 15, 2010

Does Seasonal Financial Trading Actually Work?

Many of us are curious as to how and why the markets move as they do. Some so called experts will claim you can never beat the markets as they are purely random. However is this really true?

By:
Neil Mannl

Finance>
Day Tradingl
Dec 15, 2010

Learn How the Financial Markets Really Move

Have you ever wondered why so many so called experts call the market incorrectly? Many experts rely on other experts to indicate a general trend and what then follows is a herd mentality which is then reflected in articles and press reports that you read in your newspapers and elsewhere. Of course there are exceptions to this and some experts really do seem to have an incredible knack for calling the market whether it be for the market to move higher or lower.

By:
Neil Mannl

Finance>
Day Tradingl
Dec 15, 2010

Stock Trading Education and Analysis

If you want to make handsome money in stock trading you must look for professional stock market advice. On internet you can easily find out various companies offering stock trading education for traders of all capacity.

By:
william kadutzil

Finance>
Day Tradingl
Dec 15, 2010

Fear and Greed – A Beginners Guide

The experience of a spread betting beginner. How mastering ones emotions is a big leap on the path to spread betting success.

By:
Harry Boothl

Finance>
Day Tradingl
Dec 14, 2010

Expected Pullback after Monday Gap Open

When markets gap around they get natural retracements creating volatility and if you look at a simple 5 day chart you can spot likely retracements. An example is yesterdays gap higher and todays pullback which will likely test the area it gapped from. News becomes irrelevant and pricing takes over as valuation becomes a confusing exercise making it best to trudge through the summer and its earnings quarter.

By:
World Market Medial

Marketing>
International Marketingl
Aug 04, 2010

AI Systems, Inc. Takes Flight with New Technology (OTCBB: ASYI)

Our technology revolutionizes how the airline industry will create business plans and schedules, the very core of their business. We have taken tremendously complex technology and created an elegant and simple user interface that can be used by an airline CEO, CFO, COO or any senior planner.”

By:
World Market Medial

Finance>
Currency Tradingl
Aug 04, 2010

Cereplast (Nasdaq:CERP): Rail Access for New Facility

Cereplast, Inc. (NASDAQ: CERP) a leading manufacturer of proprietary bio-based, sustainable plastics, announced today that it will soon have access to rail freight service at its recently opened facility in Seymour, Indiana.The rail spur, which is located at Seymour’s Eastside Industrial Park, will enable Cereplast to bulk ship its proprietary biodegradable plastic resins to its growing client base across the United States, and directly to U.S. port cities for shipment to clients in Asia, Europe

By:
World Market Medial

Finance>
Currency Tradingl
Aug 04, 2010

Media Earnings Ahead: Ad Dollars Still in Dysfunction Mode

One of the most difficult sectors of the stock market to pick in 2010 are Media Companies, most Portfolio Managers missed the move in the past fiscal year because Google (NASDAQ: GOOG) is an active disruptive technology which has upset the apple cart.

By:
World Market Medial

Finance>
Day Tradingl
Jul 31, 2010

CopSync (OTCBB: COYN): 8 More Sign Up’s

(OTCBB: COYN ), a software technology provider to law enforcement and emergency service professionals, announces today that eight additional Texas law enforcement agencies have implemented the Company’s COPsync(TM) real-time mobile data information sharing software.

By:
World Market Medial

Finance>
Investingl
Jul 31, 2010

HSW Intl. (Nasdaq: HSWI) : How Stuff Works +40% Online Content China

This is the second time I’ve written an artcile where this company was up big.

By:
World Market Medial

Finance>
Day Tradingl
Jul 31, 2010

Rocky Brands (Nasdaq: RCKY) Up after Posting Second Quarter Profit

After posting second quarter results yesterday, Rocky Brands (Nasdaq: RCKY) shares were up 9% to .00 on heavy volume.

By:
World Market Medial

Finance>
Investingl
Jul 31, 2010

Rocky Brands (Nasdaq: RCKY) Up after Posting Second Quarter Profit

After posting second quarter results yesterday, Rocky Brands (Nasdaq: RCKY) shares were up 9% to .00 on heavy volume.

By:
World Market Medial

Finance>
Day Tradingl
Jul 31, 2010

Add new Comment

Your :

 

Your Articles Here
It’s Free and easy

Sign Up Today

Author Navigation

My Home

View/Edit Q&A

Personal

My Home

View/Edit Q&A

Author Box

World Market Media has 304 articles online

Contact Author

Subscribe to

Print article

Send to friend

Re-Publish article

Articles Categories
All Categories

Arts & Entertainment
Automotive
Beauty
Business
Careers
Computers
Education
Finance
Food and Beverage
Health
Hobbies
Home and Family
Home Improvement
Internet
Law
Marketing
News and Society
Relationships
Self Improvement
Shopping
Spirituality
Sports and Fitness
Technology
Travel
Writing

Finance

Accounting
Banking
Credit
Currency Trading
Day Trading
Debt Consolidation
Insurance
Investing
Loans
Mortgage
Personal Finance
Real Estate
Taxes
Wealth Building

Need Help?

Site Links

Webmasters

Business Info

Use of this web site constitutes acceptance of the Terms Of Use and Privacy Policy | User published content is licensed under a Creative Commons License.
Copyright © 2005-2010 Free Articles by ArticlesBase.com, All rights reserved.

Categories: Uncategorized Tags: , , , , , , , , , , ,